AI-generated summary
The authors randomly assigned 38 patients with Parkinson's disease, aged 50 to 70, to transcranial photobiomodulation or standard treatment for 12 weeks. They report statistically significant improvements in limit of stability and functional level in the photobiomodulation group, and conclude it might be effective for posture stability and functional activity.
- Participants
- 38
- Who or what was studied
- Patients of both genders aged 50 to 70 years with Parkinson's disease, postural instability and limited functional activity
- Limits stated in the abstract
- The abstract does not report wavelengths or dosing, and it states the conclusion is tentative ("might be effective").
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Randomized controlled trial, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.